AUSTIN, Texas, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Plus Therapeutics (PSTV) and SpectronRx announced the signing of a Manufacturing Services Agreement, MSA, for the production of Rhenium ...

Tesla, seen as a key beneficiary of the so-called 'Trump Trade' thanks in part to CEO Elon Musk, is set to open at the highest levels in more than a year.

Commissions do not affect our editors' opinions or evaluations. Building a stock portfolio means sorting through mountains of data. There are thousands of publicly traded companies to compare in U ...

The partnership aims to enhance the supply chain redundancy for Plus Therapeutics and ensure that the demands of late-stage clinical trials and future commercial needs could be met effectively. This ...

(NASDAQ:PSTV), a clinical-stage pharmaceutical company ... the fourth amendment and restatement of the company's 2020 Stock Incentive Plan. The company also reported a solid financial position ...